• Users Online: 497
  • Home
  • Print this page
  • Email this page

    Article Cited by others

LETTER TO EDITOR

Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity

Shah Parag K, Morris Rodney J, Narendran V, Kalpana N

Year : 2011| Volume: 59| Issue : 1 | Page no: 73-74

   This article has been cited by
 
1 Intravitreal Anti-VEGF Therapy as a Treatment for Retinopathy of Prematurity: What We Know After 7 Years
Michael A. Klufas,R. V. Paul Chan
Journal of Pediatric Ophthalmology & Strabismus. 2015; 52(2): 77
[Pubmed]  [Google Scholar] [DOI]
2 Intravitreal anti-VEGF therapy as an adjunct to laser photocoagulation for severe aggressive posterior retinopathy of prematurity
Sengul Ozdek,Metin Unlu,Gokhan Gurelik,Berati Hasanreisoglu
Journal of Optometry. 2013; 6(1): 51
[Pubmed]  [Google Scholar] [DOI]
3 Pharmakologische Therapie der Frühgeborenenretinopathie
A. Stahl,H. Agostini,C. Jandeck,W. Lagrèze
Der Ophthalmologe. 2011; 108(8): 777
[Pubmed]  [Google Scholar] [DOI]
4 Pharmacological treatment for retinopathy of prematurity | [Pharmakologische Therapie der Frühgeborenenretinopathie]
Stahl, A., Agostini, H., Jandeck, C., Lagrèze, W.
Spektrum der Augenheilkunde. 2011; 25(5): 319-330
[Pubmed]  [Google Scholar]
5 Pharmakologische Therapie der Frühgeborenenretinopathie
A. Stahl,H. Agostini,C. Jandeck,W. Lagrèze
Spektrum der Augenheilkunde. 2011; 25(5): 319
[Pubmed]  [Google Scholar] [DOI]

 

Read this article